Artificial intelligence support in MR imaging of incidental renal masses: an early health technology assessment
OBJECTIVE: This study analyzes the potential cost-effectiveness of integrating an artificial intelligence (AI)-assisted system into the differentiation of incidental renal lesions as benign or malignant on MR images during follow-up. - MATERIALS AND METHODS: For estimation of quality-adjusted life y...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
23 February 2024
|
| In: |
European radiology
Year: 2024, Volume: 34, Issue: 9, Pages: 5856-5865 |
| ISSN: | 1432-1084 |
| DOI: | 10.1007/s00330-024-10643-5 |
| Online Access: | Verlag, kostenfrei, Volltext: https://doi.org/10.1007/s00330-024-10643-5 |
| Author Notes: | Alexander W. Marka, Johanna Luitjens, Florian T. Gassert, Lisa Steinhelfer, Egon Burian, Johannes Rübenthaler, Vincent Schwarze, Matthias F. Froelich, Marcus R. Makowski and Felix G. Gassert |
| Summary: | OBJECTIVE: This study analyzes the potential cost-effectiveness of integrating an artificial intelligence (AI)-assisted system into the differentiation of incidental renal lesions as benign or malignant on MR images during follow-up. - MATERIALS AND METHODS: For estimation of quality-adjusted life years (QALYs) and lifetime costs, a decision model was created, including the MRI strategy and MRI + AI strategy. Model input parameters were derived from recent literature. Willingness to pay (WTP) was set to $100,000/QALY. Costs of |
|---|---|
| Item Description: | Gesehen am 26.07.2024 |
| Physical Description: | Online Resource |
| ISSN: | 1432-1084 |
| DOI: | 10.1007/s00330-024-10643-5 |